Verrica Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	292	308	113	252	298	410	209
Market Cap Growth	-	172.47%	-55.17%	-15.33%	-27.31%	95.57%	-
Enterprise Value	265	284	80	225	269	348	119
PE Ratio	-4.60	-4.60	-4.61	-7.19	-6.97	-14.52	-10.14
PS Ratio	56.46	60.09	12.51	21.01	-	-	-
PB Ratio	14.64	15.58	2.82	7.73	9.03	6.30	2.34
P/FCF Ratio	-7.91	-7.91	-5.96	-8.86	-9.40	-14.58	-11.23
P/OCF Ratio	-7.98	-7.98	-6.06	-9.14	-9.86	-14.94	-11.72
EV/Sales Ratio	51.77	55.40	8.89	18.76	-	-	-
EV/EBITDA Ratio	-4.56	-4.56	-3.72	-7.43	-6.83	-12.44	-5.77
EV/EBIT Ratio	-4.50	-4.50	-3.60	-7.31	-6.79	-12.33	-5.77
EV/FCF Ratio	-7.29	-7.29	-4.23	-7.91	-8.51	-12.38	-6.39
Debt / Equity Ratio	2.30	2.30	0.04	1.33	1.13	0.00	-
Debt / EBITDA Ratio	-0.73	-0.73	-0.07	-1.43	-0.94	-0.01	-
Debt / FCF Ratio	-1.17	-1.17	-0.08	-1.52	-1.17	-0.01	-
Quick Ratio	4.34	4.34	10.05	1.53	1.66	18.51	36.46
Current Ratio	4.55	4.55	11.31	1.61	1.71	19.39	36.80
Asset Turnover	0.07	0.07	0.16	0.13	0	0	0
Interest Coverage	-15.91	-15.91	-10.27	-7.17	-13.07	-	-
Return on Equity (ROE)	-147.00%	-147.00%	-77.40%	-74.90%	-96.40%	-38.10%	-29.60%
Return on Assets (ROA)	-86.60%	-86.60%	-42.80%	-37.30%	-50.90%	-36.20%	-25.40%
Return on Capital (ROIC)	-100.74%	-100.74%	-51.24%	-40.66%	-57.24%	-46.13%	-24.46%
Earnings Yield	-23.16%	-21.76%	-21.67%	-13.92%	-14.34%	-6.89%	-9.86%
FCF Yield	-13.46%	-12.65%	-16.77%	-11.29%	-10.64%	-6.86%	-8.90%
Buyback Yield / Dilution	-32.72%	-32.72%	-26.32%	-8.20%	-0.39%	-69.80%	-414.43%
Total Shareholder Return	-32.72%	-32.72%	-26.32%	-8.20%	-0.39%	-69.80%	-414.43%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).